WELL.V - WELL Health Technologies Corp.

TSXV - TSXV Delayed Price. Currency in CAD
1.3100
-0.0200 (-1.50%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.3300
Open1.3300
Bid1.3100 x 0
Ask1.3400 x 0
Day's Range1.2800 - 1.3500
52 Week Range0.3600 - 1.8700
Volume109,375
Avg. Volume368,274
Market Cap127.842M
Beta (3Y Monthly)1.91
PE Ratio (TTM)N/A
EPS (TTM)-0.0360
Earnings DateAug 22, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.54
  • CNW Group

    WELL Health Announces Normal Course Issuer Bid

    VANCOUVER , Oct. 11, 2019 /CNW/ - WELL Health Technologies Corp. (WELL.V) ("WELL" or the "Company"), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, today announced that the TSX Venture Exchange has accepted its Notice of an Intention to Make a Normal Course Issuer Bid which shall commence on October 17, 2019 and terminate on October 16, 2020 , or such earlier date if the maximum number of shares are purchased. At the opening of the stock market on today's date, the Company is expected to have 108,324,535 common shares issued and outstanding following the conversion of the previously announced special warrants financing of the Company.

  • CNW Group

    WELL Health Announces Receipt for Final Short Form Prospectus

    VANCOUVER , Oct. 7, 2019 /CNW/ - WELL Health Technologies Corp. (WELL.V) ("WELL" or the "Company"), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, is pleased to announce that, further to its news release dated August 15, 2019 , on October 4, 2019 , the Company received a receipt (the "Final Receipt") for its final short form prospectus dated October 4, 2019 (the "Prospectus"). The Prospectus qualifies the distribution of an aggregate of 10,350,000 common shares of the Company (the "Shares"), which are issuable for no additional consideration upon the exercise or deemed exercise of 10,350,000 special warrants (the "Special Warrants") sold in an underwritten private placement offering completed by the Company on August 15, 2019 (the "Offering").

  • CNW Group

    WELL Health Completes Acquisition of Majority Stake in SleepWorks Medical Inc.

    WELL Health completes acquisition of 51% of private company, SleepWorks Medical Inc. ("SleepWorks"). SleepWorks is a leader in providing services for patients who suffer from sleep disorders. Since inception, SleepWorks has provided diagnostic services to over 10,000 patients.

  • CNW Group

    WELL Health to Present at the StableView TECH19 Conference In Toronto, ON

    WELL Health to Present at the StableView TECH19 Conference In Toronto, ON

  • CNW Group

    WELL Health forms "WELL EMR Group", launches OSCAR McMaster Professional Edition with McMaster University and achieves OntarioMD EMR Certification

    WELL Health forms "WELL EMR Group", launches OSCAR McMaster Professional Edition with McMaster University and achieves OntarioMD EMR Certification

  • CNW Group

    WELL Health Announces Agreement to Acquire EMR Service Provider OSCARwest

    OSCARwest provides OSCAR1 EMR services to 90 medical clinics in British Columbia , supporting over 1100 registered physicians and practitioners. With the proposed acquisition of OSCARwest, WELL will increase its EMR footprint to supporting 946 primary health medical clinics and over 6,000 registered physicians and practitioners across Canada . OSCARwest will be WELL's third acquisition of an OSCAR Electronic Medical Records (EMR) service provider in British Columbia , which positions the Company as one of the dominant EMR service providers in the province.

  • CNW Group

    WELL Health to Present at the Extraordinary Future Conference In Vancouver, BC

    WELL Health to Present at the Extraordinary Future Conference In Vancouver, BC

  • CNW Group

    Financial Buzz Media Networks Official Media Partner of Cambridge House International's XFuture Conference September 22-23, 2019

    Financial Buzz Media Networks Official Media Partner of Cambridge House International's XFuture Conference September 22-23, 2019

  • CNW Group

    WELL Health Announces Completion of Time-Based Earn Out Payment in Connection with Previously Announced Acquisition of Private HealthCare Clinics

    WELL Health Announces Completion of Time-Based Earn Out Payment in Connection with Previously Announced Acquisition of Private HealthCare Clinics

  • CNW Group

    WELL Health Reports Record Revenue for Second Quarter 2019

    WELL Health Reports Record Revenue for Second Quarter 2019

  • CNW Group

    WELL Health to Host Second Quarter 2019 Investor Conference Call

    WELL Health to Host Second Quarter 2019 Investor Conference Call

  • CNW Group

    WELL Health Completes Upsized Bought Deal Private Placement of Special Warrants

    VANCOUVER , Aug. 15, 2019 /CNW/ - WELL Health Technologies Corp. (WELL.V) ("WELL" or the "Company") is pleased to announce that, further to its news releases dated July 25, 2019 and July 29, 2019 , the Company has completed its previously announced upsized bought deal private placement of 10,350,000 special warrants of the Company (each, a "Special Warrant"), including 1,350,000 Special Warrants issued pursuant to the over-allotment option which was exercised in full, at a price of $1.45 per Special Warrant for gross proceeds of $15,007,500 (the "Offering"). "We are very pleased to receive such robust institutional support from new and existing investors to complete this upsized offering," said Hamed Shahbazi , CEO of WELL Health.

  • CNW Group

    WELL Health Announces Time-Based Earn Out Payment in Connection with Acquisition of Private HealthCare Clinics Completed in November 2018

    VANCOUVER , Aug. 6, 2019 /CNW/ - WELL Health Technologies Corp. (WELL.V) (the "Company" or "WELL"), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, announces, further to its news release dated November 1 st, 2018, the Company paid $96,789 in cash and intends to issue an aggregate of 14,933 shares in accordance with the acquisition agreements whereby the Company acquired all of the issued and outstanding shares of 13 target companies operating an aggregate of 13 Healthcare Clinics in British Columbia . The issuance of the shares is subject to the approval of the TSX Venture Exchange (the "TSXV").

  • CNW Group

    WELL Health to Present at the Canaccord Genuity Growth Conference

    WELL Health to Present at the Canaccord Genuity Growth Conference

  • CNW Group

    WELL Health Announces Increase in Previously Announced Bought Deal Private Placement of Special Warrants

    VANCOUVER , July 29, 2019 /CNW/ - WELL Health Technologies Corp. (WELL.V) ("WELL" or the "Company") is pleased to announce that it has amended the terms of its previously announced bought deal of approximately $12.0 million with an increase to 9,000,000 special warrants of the Company (the "Special Warrants") at a price per Special Warrant of $1.45 for aggregate gross proceeds of approximately $13.0 million (the "Offering"). The Underwriters will also have the option, exercisable up to two business days prior to the closing date of the Offering, to arrange for the purchase of up to an additional 1,350,000 special warrants at the Offering Price for additional gross proceeds of approximately $2.0 million . In the event that the option is exercised in its entirety, the aggregate gross proceeds would increase to approximately $15.0 million .

  • CNW Group

    WELL Health Technologies Corp. Announces $12.0 Million Bought Deal Private Placement of Special Warrants

    VANCOUVER , July 25, 2019 /CNW/ - WELL Health Technologies Corp. (WELL.V) ("WELL" or the "Company")  announces that it has entered into an agreement with a syndicate of underwriters led by GMP Securities L.P. (collectively, the "Underwriters") for an offering on a bought deal private placement basis of 8,276,000 special warrants of the Company (the "Special Warrants") at a price per Special Warrant of $1.45 for aggregate gross proceeds of approximately $12.0 million (the "Offering"). The Company has also granted the Underwriters an option to purchase up to an additional 15% of the base offering of Special Warrants, which option is exercisable by giving notice to the Company not less than 48-hours prior to the closing of the Offering.

  • CNW Group

    /R E P E A T -- WELL Health to Acquire Majority Stake in SleepWorks Medical Inc./

    SleepWorks Medical is a leader in providing services for patients who suffer from sleep disorders. Since inception, SleepWorks has provided diagnostic services to over 10,000 patients. This transaction is immediately accretive to WELL Health.

  • CNW Group

    WELL Health to Acquire Majority Stake in SleepWorks Medical Inc.

    SleepWorks Medical is a leader in providing services for patients who suffer from sleep disorders. Since inception, SleepWorks has provided diagnostic services to over 10,000 patients. This transaction is immediately accretive to WELL Health.

  • CNW Group

    WELL Health Completes Acquisition of Kai Innovations, Canada's largest provider of OSCAR EMR Services

    KAI's award winning founders, Arjun Kumar and Sara Bond have joined WELL's technology management team and will help drive the digital health portfolio of the company. VANCOUVER , July 2, 2019 /CNW/ - WELL Health Technologies Corp. (WELL.V) (the "Company" or "WELL"), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, is pleased to announce the closing of its previously announced acquisition (the "Acquisition") of Kela Atlantic Inc. dba KAI Innovations ("KAI").

  • CNW Group

    WELL Health Technologies Corp. Announces Closing of $10,500,000 Bought Deal Private Placement of Convertible Debentures Including the Full Exercise of Over-Allotment Option

    VANCOUVER , June 13, 2019 /CNW/ - WELL Health Technologies Corp. (WELL.V) ("WELL" or the "Company") announced today that it has closed its previously announced bought deal private placement offering, including the exercise in full of the underwriters' over-allotment option. A total of $10,500,000 aggregate principal amount of senior unsecured convertible debentures (the "Convertible Debentures") of the Company were sold at a price of $1,000 per Convertible Debenture (the "Offering"), with $9,500,000 aggregate principal amount of Convertible Debentures issued on the date hereof and a further tranche of $1,000,000 aggregate principal amount of Convertible Debentures to be issued on or before June 20, 2019 , subject to receipt of funds.

  • CNW Group

    WELL Health Completes Acquisition of EMR service provider OSCARprn

    Treatment Solutions Ltd. ("OSCARprn"), which expands WELL's digital portfolio in Electronic Medical Records (EMR). OSCARprn provides SaaS (Software as a Service) EMR services to approximately 71 clinics in British Columbia , supporting approximately 820 registered doctors and practitioners, and over 800,000 unique patient profiles1. With the acquisition of OSCARprn, WELL has increased its EMR footprint to now supporting approximately 292 clinics and over 5.5 million patients.

  • CNW Group

    WELL Health Technologies Corp. Announces Increase in Previously Announced Bought Deal Financing

    VANCOUVER , June 4, 2019 /CNW/ - WELL Health Technologies Corp. (WELL.V) ("WELL" or the "Company") is pleased to announce that it has amended the terms of its previously announced bought deal with an increase to the Underwriter's Option from $1,500,000 to $2,500,000 . The Offering is being underwritten by GMP Securities L.P. (the "Lead Underwriter" and, collectively with the syndicate, the "Underwriters"). If the Underwriters' Option is exercised in full, the aggregate gross proceeds of the Offering will be $10,500,000 .

  • CNW Group

    WELL Health Technologies Corp. Announces $8,000,000 Bought Deal Private Placement of Convertible Debentures

    VANCOUVER , May 30, 2019 /CNW/ - WELL Health Technologies Corp. (WELL.V) ("WELL" or the "Company") announced today that it has entered into an agreement with a syndicate of underwriters led by GMP Securities L.P. (the "Lead Underwriter" and, collectively with the syndicate, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement basis, $8,000,000 aggregate principal amount of convertible debentures (the "Convertible Debentures") of the Company at a price of $1,000 per Convertible Debenture (the "Offering").